Vera Therapeutics Inc (VERA): Next-Year EPS Estimate 38.86%
As of 2026-06-11, Vera Therapeutics Inc (VERA) has a next-year EPS growth estimate of 38.86%.
On 2026-06-02, analyst consensus for VERA's next-year EPS growth shifted from 40.91% to 38.86% — a negative change of 2.05 percentage points. The revised estimate has been sustained across 8 subsequent trading sessions. Current-year growth is projected at -30.91%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 38.86%
- EPS growth this year
- -30.91%
- EPS next quarter (est)
- -$1.62
- Last price
- $33.65
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 38.86% | -30.91% | -$1.62 | $33.65 |
| 2026-06-10 | 38.86% | -30.91% | -$1.62 | $31.62 |
| 2026-06-09 | 38.86% | -30.91% | -$1.62 | $31.81 |
| 2026-06-08 | 38.86% | -30.91% | -$1.62 | $31.75 |
| 2026-06-07 | 38.86% | -30.90% | -$1.62 | $32.29 |
| 2026-06-04 | 38.86% | -30.90% | -$1.60 | $33.38 |
| 2026-06-03 | 38.86% | -30.90% | -$1.60 | $31.27 |
| 2026-06-02 | 38.86% | -30.90% | -$1.60 | $31.26 |
| 2026-06-01 | 40.91% | -30.20% | -$1.60 | $33.94 |
| 2026-05-31 | 40.91% | -30.20% | -$1.60 | $35.52 |
| 2026-05-28 | 40.91% | -30.20% | -$1.60 | $35.86 |
| 2026-05-27 | 40.91% | -30.20% | -$1.60 | $34.27 |
| 2026-05-26 | 40.91% | -30.20% | -$1.60 | $34.34 |
| 2026-05-25 | 40.91% | -30.20% | -$1.60 | $34.04 |
| 2026-05-24 | 40.91% | -30.20% | -$1.60 | $34.04 |
| 2026-05-21 | 41.20% | -29.74% | -$1.60 | $34.35 |
| 2026-05-20 | 41.20% | -29.74% | -$1.60 | $34.62 |
| 2026-05-19 | 41.20% | -29.74% | -$1.60 | $33.25 |
| 2026-05-18 | 40.07% | -27.79% | -$1.61 | $34.35 |
| 2026-05-17 | 40.07% | -27.79% | -$1.61 | $37.32 |
| 2026-05-14 | 39.33% | -26.47% | -$1.61 | $39.56 |
| 2026-05-13 | 39.33% | -26.47% | -$1.61 | $38.54 |
| 2026-05-12 | 38.99% | -24.16% | -$1.57 | $36.70 |
| 2026-05-11 | 38.72% | -21.30% | -$1.52 | $36.61 |
| 2026-05-10 | 39.72% | -20.09% | -$1.52 | $36.19 |
| 2026-05-07 | 39.28% | -15.60% | -$1.43 | $35.88 |
| 2026-05-06 | 39.09% | -12.82% | -$1.33 | $36.60 |
| 2026-05-05 | 39.09% | -12.82% | -$1.33 | $34.52 |
| 2026-05-04 | 39.09% | -12.82% | -$1.33 | $35.51 |
| 2026-05-03 | 39.09% | -12.82% | -$1.33 | $35.20 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Vera Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Vera Therapeutics Inc (VERA) has a next-year EPS growth estimate of 38.86%, based on analyst consensus.
When was the latest EPS estimate revision for VERA?▾
The most recent revision occurred on 2026-06-02, when analysts adjusted the next-year EPS growth estimate from 40.91% to 38.86%.
What sector and industry does Vera Therapeutics Inc belong to?▾
Vera Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. VERA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Vera Therapeutics Inc (VERA) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports